|
ES2349762T3
(es)
|
2000-08-10 |
2011-01-11 |
Pfizer Italia S.R.L. |
Biciclo-pirazoles activos como inhibidores de quinasas, procedimientos para su preparación y composiciones farmacéuticas que los comprenden.
|
|
TW200716628A
(en)
|
2005-03-22 |
2007-05-01 |
Astrazeneca Ab |
Novel compounds
|
|
FR2884252B1
(fr)
|
2005-04-08 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives d'isoindoles, compositions les contenant, leur preparation et leurs utilisations pharmaceutiques notamment en tant qu'inhibiteurs d'activites de la proteine chaperone hsp90
|
|
AR058223A1
(es)
|
2005-11-25 |
2008-01-23 |
Palau Pharma Sa |
Un comuesto de derivados de pirazoloisoquinolina, un procedimiento para l a preparacion de dicho compuesto y una composicion farmaceutica que comprende dicho compuesto
|
|
EP2223925A1
(en)
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
US20120157402A1
(en)
|
2009-05-27 |
2012-06-21 |
Liangxian Cao |
Methods for treating brain tumors
|
|
MX373926B
(es)
|
2009-05-27 |
2020-07-10 |
Ptc Therapeutics Inc |
Metodos para tratar cancer y estados no neoplasicos.
|
|
US20120157401A1
(en)
|
2009-05-27 |
2012-06-21 |
Ptc Therapeutics, Inc. |
Methods for treating neurofibromatosis
|
|
HUE033581T2
(hu)
|
2010-06-10 |
2017-12-28 |
Seragon Pharmaceuticals Inc |
Ösztrogén receptor modulátorok és alkalmazásaik
|
|
US8853423B2
(en)
|
2010-06-17 |
2014-10-07 |
Seragon Pharmaceuticals, Inc. |
Indane estrogen receptor modulators and uses thereof
|
|
JP6112625B2
(ja)
|
2011-12-14 |
2017-04-12 |
セラゴン ファーマシューティカルズ，インク． |
フッ素化したエストロゲン受容体モジュレーターおよびその使用
|
|
US10987334B2
(en)
*
|
2012-07-13 |
2021-04-27 |
University Of Tennessee Research Foundation |
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
|
|
PT2872482T
(pt)
*
|
2012-07-13 |
2020-09-22 |
Oncternal Therapeutics Inc |
Método de tratamento de cancro de mama com modulador seletivo do recetor de andrógeno (sarm)
|
|
TWI653235B
(zh)
|
2013-05-28 |
2019-03-11 |
阿斯特捷利康公司 |
作為抗癌劑之吲哚衍生物
|
|
EA031077B1
(ru)
|
2013-06-19 |
2018-11-30 |
Серагон Фармасьютикалз, Инк. |
Модулятор рецептора эстрогена и его применения
|
|
BR112015030595A2
(pt)
|
2013-06-19 |
2017-07-25 |
Seragon Pharmaceuticals Inc |
moduladores de receptor de estrogênio de azetidina e usos dos mesmos
|
|
WO2015092634A1
(en)
|
2013-12-16 |
2015-06-25 |
Novartis Ag |
1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
|
|
CN107406424B
(zh)
|
2014-12-18 |
2020-08-25 |
豪夫迈·罗氏有限公司 |
雌激素受体调节剂及其用途
|
|
KR102785474B1
(ko)
|
2014-12-18 |
2025-03-26 |
에프. 호프만-라 로슈 아게 |
테트라하이드로-피리도[3,4-b]인돌 에스트로겐 수용체 조절제 및 이의 용도
|
|
EP3233818A1
(en)
|
2014-12-18 |
2017-10-25 |
F. Hoffmann-La Roche AG |
Derivatives of 2,3-diphenylchromene useful for the treatment of cancer
|
|
WO2016174551A1
(en)
|
2015-04-27 |
2016-11-03 |
Pfizer Inc. |
Anti-estrogenic compounds
|
|
JP7019422B2
(ja)
*
|
2015-04-29 |
2022-02-15 |
ラジウス ファーマシューティカルズ，インコーポレイテッド |
癌を治療するための方法
|
|
EP3303326B1
(en)
|
2015-05-26 |
2020-12-16 |
H. Hoffnabb-La Roche Ag |
Heterocyclic estrogen receptor modulators and uses thereof
|
|
KR20180012853A
(ko)
|
2015-06-16 |
2018-02-06 |
지앙수 헨그루이 메디슨 컴퍼니 리미티드 |
피페리딘 유도체 및 이의 제조 방법 및 약학적 용도
|
|
CN106518768B
(zh)
|
2015-09-15 |
2021-07-02 |
江苏恒瑞医药股份有限公司 |
丙烯酸类衍生物、其制备方法及其在医药上的应用
|
|
KR102710603B1
(ko)
|
2015-10-01 |
2024-09-27 |
올레마 파마슈티컬스 인코포레이티드 |
테트라히드로-1H-피리도[3,4-b]인돌 항에스트로겐 약물
|
|
US10399939B2
(en)
|
2015-11-09 |
2019-09-03 |
Genentech, Inc. |
Tetrahydronaphthalene estrogen receptor modulators and uses thereof
|
|
US10519148B2
(en)
|
2015-11-12 |
2019-12-31 |
Zhejiang Hisun Pharmaceutical Co., Ltd. |
Acrylic acid derivative, preparation method and use in medicine thereof
|
|
MX2018007844A
(es)
|
2015-12-22 |
2019-01-21 |
Jiangsu Hengrui Medicine Co |
Derivado de benzopiperidina, metodo de preparacion del mismo y su uso medico del mismo.
|
|
KR20180119570A
(ko)
*
|
2016-03-15 |
2018-11-02 |
메리맥 파마슈티컬즈, 인크. |
항-ErbB3 항체를 포함하는 병용 요법을 이용한 ER+, HER2-, HRG+ 유방암의 치료
|
|
US9969732B2
(en)
|
2016-04-08 |
2018-05-15 |
Genentech, Inc. |
Tetrahydroisoquinoline estrogen receptor modulators and uses thereof
|
|
US10125135B2
(en)
|
2016-04-20 |
2018-11-13 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2017192991A1
(en)
|
2016-05-06 |
2017-11-09 |
Xavier University Of Louisiana |
Selective estrogen receptor down-regulators (serds)
|
|
WO2018001232A1
(zh)
|
2016-06-29 |
2018-01-04 |
浙江海正药业股份有限公司 |
丙烯酸类衍生物及其制备方法和其在医药上的用途
|
|
WO2018019793A1
(en)
|
2016-07-25 |
2018-02-01 |
Astrazeneca Ab |
N-(2-(4-((1r,3r)-3-methyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-1-yl)phenoxy)ethyl)propan-1-amine derivatives and related compounds as selective down-regulators of the estrogen receptor for treating cancer
|
|
CN107814798B
(zh)
|
2016-09-14 |
2020-11-03 |
四川科伦博泰生物医药股份有限公司 |
3-取代丙烯酸类化合物及其制备方法和用途
|
|
WO2018053354A1
(en)
|
2016-09-15 |
2018-03-22 |
Arvinas, Inc. |
Indole derivatives as estrogen receptor degraders
|
|
BR102016024814A2
(pt)
|
2016-10-24 |
2018-05-08 |
Aché Laboratórios Farmacêuticos S.A. |
composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono
|
|
TWI735681B
(zh)
|
2016-10-24 |
2021-08-11 |
瑞典商阿斯特捷利康公司 |
化合物
|
|
EP3555064B9
(en)
|
2016-12-16 |
2023-03-01 |
Pfizer Inc. |
Glp-1 receptor agonists and uses thereof
|
|
TWI831738B
(zh)
|
2016-12-16 |
2024-02-11 |
美商瑞塔醫藥有限責任公司 |
用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物
|
|
KR102276022B1
(ko)
|
2016-12-16 |
2021-07-13 |
일라이 릴리 앤드 캄파니 |
돌연변이체 idh1 및 idh2 억제제로서의 7-페닐에틸아미노-4h-피리미도[4,5-d][1,3]옥사진-2-온 화합물
|
|
LT3555097T
(lt)
|
2016-12-16 |
2022-08-25 |
Janssen Pharmaceutica Nv |
Imidazo[4,5-d]pirolo[2,3-b]piridino junginiai kaip janus kinazės inhibitoriai
|
|
JOP20190144A1
(ar)
|
2016-12-16 |
2019-06-16 |
Janssen Pharmaceutica Nv |
إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
|
|
CA3045224A1
(en)
|
2016-12-16 |
2018-06-21 |
Basf Se |
Pesticidal compounds
|
|
ES2866152T3
(es)
|
2017-01-30 |
2021-10-19 |
Chiesi Farm Spa |
Derivados de tirosina amida como inhibidores de la Rho-quinasa
|